Transcripts
Biogen Inc Evaluation of aducanumab safety in early Alzheimer's disease at AD/PD Transcript
2021-03-13Corporate Presentation
Read the full earnings transcript with Waltermetrics Pro
The complete transcript text is available to Pro members.
Upgrade to Pro